Among the already known RRM1 SNPs, −37C>A (rs12806698) and −524C>T (rs11030918) seem to have the greatest importance as potential predictors of treatment regimens based on gemcitabine in NSCLC patients [15–17]. The gene discussed is RRM1; the disease is non-small cell lung carcinoma.